+ND Capital

Menlo Park, California
Firm Location:Menlo Park, California • San Francisco Bay Area • United Kingdom • Switzerland
+ND Capital Team
Photo of Klaus Dugi, Venture Partner at +ND Capital
Klaus Dugi
+ND Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Photo of Gabriela Ecco, Principal at +ND Capital
Gabriela Ecco
+ND Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Photo of Kirill Kuzmichev, Principal at +ND Capital
Kirill Kuzmichev
+ND Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Photo of Alison Palmer, Vice President at +ND Capital
Alison Palmer
+ND Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Photo of Aymeric Sallin, Investor at +ND Capital
Aymeric Sallin
+ND Capital·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Menlo Park (CA)
Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in AI (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)